The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti–Vascular Endothelial Growth Factor Injections
- 18 May 2021
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 128 (11), 1620-1626
- https://doi.org/10.1016/j.ophtha.2021.05.010
Abstract
No abstract availableKeywords
Funding Information
- American Academy of Ophthalmology
- Boehringer Ingelheim
- Johnson and Johnson
This publication has 21 references indexed in Scilit:
- Predictors of Endophthalmitis after Intravitreal InjectionOphthalmology Retina, 2019
- Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti–Vascular Growth Factor Agents in a Nationwide Study in FranceJAMA Ophthalmology, 2018
- Effect of a Strict ‘No-Talking’ Policy During Intravitreal Injection on Post-Injection EndophthalmitisOphthalmic Surgery, Lasers and Imaging Retina, 2015
- Postmarketing Analysis of Aflibercept-Related Sterile Intraocular InflammationJAMA Ophthalmology, 2015
- The Role of Topical Antibiotic Prophylaxis to Prevent Endophthalmitis after Intravitreal InjectionOphthalmology, 2014
- Bacterial Dispersal Associated With Speech in the Setting of Intravitreous InjectionsAmerican Journal of Ophthalmology, 2011
- Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor AgentsOphthalmology, 2011
- REDUCING ORAL FLORA CONTAMINATION OF INTRAVITREAL INJECTIONS WITH FACE MASK OR SILENCERetina, 2011
- NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTSRetina, 2010
- Functional Status and Quality of Life Measurement Among Ophthalmic PatientsAmerican Journal of Ophthalmology, 1994